secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001773751-24-000023
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers FY2023 revenue $872M (+65% YoY); Q4 net income $1.2M; guides FY2024 rev $1.17-1.20B
--------------------------------------------------------------------------------

- FY2023 revenue $872.0M, up 65% YoY; net loss improved to $(23.5)M from $(65.7)M.
- Q4 2023 revenue $246.6M (+47% YoY); first net income quarter of $1.2M vs $(10.9)M loss.
- Adjusted EBITDA Q4 $20.6M vs $3.9M; FY2023 Adj. EBITDA $49.5M vs $(15.8M) loss.
- Subscribers reached 1.54M, up 48% YoY; monthly online revenue per subscriber $53.
- Guides FY2024 revenue $1.17B-$1.20B; Adj. EBITDA $100M-$120M, beating 2025 target early.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/0001773751-24-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/hims-20240226.htm
  HTML page:      https://secwatch.observer/filing/0001773751-24-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer